Literature DB >> 33150828

COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India.

Venkatraman Radhakrishnan1, Jerin Ovett1, Aruna Rajendran2, Saikrishna Kolluru1, Vishwajeeth Pai1, Vijay Gnanaguru1, Manikandan Dhanushkodi1, Jayachandran Perumal Kalaiyarasi1, Nikita Mehra1, Gangothri Selvarajan1, Arun Kumar Rajan1, Parathan Karunakaran1, Sivasree Kesana1, Tenali Sagar1.   

Abstract

Crowded outpatient clinics and common wards in many hospitals in low and middle-income countries predispose children, caregivers, and health care workers to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report on the clinical features and outcomes of 15 children with cancer at our center who tested positive for SARS-CoV-2. Five out of 15 patients were symptomatic, and one patient required intensive care and respiratory support. All the patients in the study have recovered from the SARS-CoV-2 infection without any sequelae and have resumed their cancer treatment.

Entities:  

Keywords:  COVID19; SARS-CoV-2; pediatric cancer

Mesh:

Year:  2020        PMID: 33150828     DOI: 10.1080/08880018.2020.1831113

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  5 in total

1.  COVID-19 in Children with Cancer and Continuation of Cancer-Directed Therapy During the Infection.

Authors:  Badira Cheriyalinkal Parambil; Nirmalya Roy Moulik; Chetan Dhamne; Nidhi Dhariwal; Gaurav Narula; Tushar Vora; Maya Prasad; Akanksha Chichra; Shalini Jatia; Girish Chinnaswamy; Shripad Banavali
Journal:  Indian J Pediatr       Date:  2021-08-11       Impact factor: 5.319

Review 2.  COVID-19 outcomes in paediatric cancer: A large scale pooled meta-analysis of 984 cancer patients.

Authors:  Amr Ehab El-Qushayri; Amira Yasmine Benmelouka; Abdullah Dahy; Mohammad Rashidul Hashan
Journal:  Rev Med Virol       Date:  2022-03-05       Impact factor: 11.043

3.  Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India.

Authors:  Sumeet P Mirgh; Anant Gokarn; Akhil Rajendra; Ashwini More; Sujit Kamtalwar; Kritika S Katti; Anuj Singh; Vasu Babu Goli; Rahul Ravind; Ravikrishna Madala; Sangeeta Kakoti; Priyamvada Maitre; Sachin Punatar; Akanksha Chichra; Amar Patil; Bhakti Trivedi; Amit Joshi; Nikhil Patkar; Prashant Tembhare; Twinkle Khanka; Sweta Rajpal; Gaurav Chatterjee; Sadhana Kannan; P G Subramanian; Vedang Murthy; Nitin Shetty; Preeti Chavan; Vivek Bhat; Sudhir Nair; Navin Khattry; Sudeep Gupta
Journal:  Cancer Med       Date:  2021-11-16       Impact factor: 4.711

4.  Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.

Authors:  Rachel Harwood; Helen Yan; Nishanthi Talawila Da Camara; Clare Smith; Joseph Ward; Catrin Tudur-Smith; Michael Linney; Matthew Clark; Elizabeth Whittaker; Defne Saatci; Peter J Davis; Karen Luyt; Elizabeth S Draper; Simon E Kenny; Lorna K Fraser; Russell M Viner
Journal:  EClinicalMedicine       Date:  2022-02-11

Review 5.  COVID-19 in Children with Cancer.

Authors:  Alissa R Kahn; Carla M Schwalm; Julie Ann Wolfson; Jennifer M Levine; Emily E Johnston
Journal:  Curr Oncol Rep       Date:  2022-02-03       Impact factor: 5.945

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.